Approach to fluid management in peritoneal dialysis: A practical algorithm

Kidney International, Supplement

Volumn 62, Issue 81, 2002, Pages S8-S16

  Abu Alfa, Ali K ^a,b,c,d   Burkart, John ^a,b,c,d   Piraino, Beth ^a,b,c,d   Pulliam, Joe ^a,b,c,d   Mujais, Salim ^a,b,c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; FLUID THERAPY; HUMAN; PERITONEAL DIALYSIS; REVIEW; TREATMENT OUTCOME; BLOOD PRESSURE REGULATION; CONGESTIVE HEART FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CORONARY ARTERY DISEASE; EVALUATION; FLUID RETENTION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODIALYSIS; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; ULTRAFILTRATION;

ALGORITHMS; FLUID THERAPY; HUMANS; PERITONEAL DIALYSIS; TREATMENT OUTCOME;

BETA 2 MICROGLOBULIN;

EID: 0036379473     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.62.s81.3.x     Document Type: Review

References (65)

1. TZAMALOUKAS AH, SADDLER MC, MURATA GH, et al: Symptomatic fluid retention in patients on continuous peritoneal dialysis. J Am Soc Nephrol 6:198-206, 1995
2. FRANKENfIELD DL, PROWANT BF, FLANIGAN MJ, et al: Trends in clinical indicators of care for adult peritoneal dialysis patients in the United States from 1995 to 1997. ESRD Core Indicators Work-group. Kidney Int 55:1998-2010, 1999
3. COCCHI R, ESPOSTI ED, FABBRI A, et al: Prevalence of hypertension in patients on peritoneal dialysis: Results of an Italian multicentre study. Nephrol Dial Transplant 14:1536-1540, 1999
4. ATES K, NERGIZOGLU G, KEVEN K, et al: Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 60:767-776, 2001
5. MOIST LM, PORT FK, ORZOL SM, et al: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11:556-564, 2000
6. GÜNAL AI, DUMAN S, OZKAHYA M, et al: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 37:588-593, 2001
7. MUJAIS S, NOLPH K, GOKAL R, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 20(Suppl 4):S5-S21, 2000
8. MUJAIS S: Ultrafiltration management in automated peritoneal dialysis. Contrib Nephrol 129:255-266, 1999
9. MEDCALF JF, HARRIS KP, WALLS J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59:1128-1133, 2001
10. KIM DJ, DO JH, HUH W, et al: Dissociation between clearances of small and middle molecules in incremental peritoneal dialysis. Perit Dial Int 21:462-466, 2001
11. MISTRY CD, GOKAL R, PEERS E: MIDAS Study Group: A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503, 1994
12. GOKAL R, MISTRY CD, PEERS E: A United Kingdom multicenter study of icodextrin in continuous ambulatory peritoneal dialysis (MIDAS). Perit Dial Int 14(Suppl 2):S22-S27, 1994
13. PLUM J, GENTILE S, VERGER C, et al: Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 39:862-871, 2002
14. WOODROW G, STABLES G, OLDROYD B, et al: Comparison of icodex-trin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 14:1530-1535, 1999
15. PAZART LH, MATTILON Y, MASSOL J: Problems with guidelines. Clinical practice must be taken into account when guidelines are drawn up. BMJ 314:518-519, 1997
16. WEST E, NEWTON J: Clinical guidelines. (Editorial) BMJ 315:324, 1997
17. CAMPBELL H, HOTCHKISS R, BRADSHAW N, PORTEOUS M: Integrated care pathways. BMJ 316:133-137, 1998
18. JACKSON R, FEDER G: Guidelines for clinical guidelines. BMJ 317:427-428, 1998
19. GROL R, DALHUIJSEN J, THOMAS S, et al: Attributes of clinical guidelines that influence use of guidelines in general practice: Observational study. BMJ 317:858-861, 1998
20. SHEKELLE PG, WOOLF SH, ECCLES M, GRIMSHAW J: Clinical guidelines: Developing guidelines. BMJ 318:593-596, 1999
21. WOOLF SH, GROL R, HUTCHINSON A, et al: Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines. BMJ 318:527-530, 1999
22. HAYCOX A, BAGUST A, WALLEY T: Clinical guidelines - The hidden costs. BMJ 318:391-393, 1999
23. HURWITZ B: Legal and political considerations of clinical practice guidelines. BMJ 318:661-664, 1999
24. FEDER G, ECCLES M, GROL R, et al: Clinical guidelines: Using clinical guidelines. BMJ 318:728-730, 1999
25. CHARRA B, BERGSTROM J, SCRIBNER BH: Blood pressure control in dialysis patients: importance of the lag phenomenon. Am J Kidney Dis 32:720-724, 1998
26. CHARRA B, CHAZOT C, LAURENT G: Hypertension/hypotension in dialysis. (letter) Kidney Int 55:1128, 1999
27. JOHNSON RJ, HERRERA-ACOSTA J, SCHREINER GF, RODRIGUEZ-ITURBE B: Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346:913-923, 2002
28. LEYPOLDT JK, CHEUNG AK, DELMEZ JA, et al: Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int 61:266-275, 2002
29. JAEGER JQ, MEHTA RL: Assessment of dry weight in hemodialysis: an overview. J Am Soc Nephrol 10:392-403, 1999
30. BIANCHI G: Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis. Nephrol Dial Transplant 15(Suppl 5):105-110, 2000
31. WATSON RD, GIBBS CR, LIP GY: ABC of heart failure. Clinical features and complications. BMJ 320:236-239, 2000
32. DISKIN CJ, STOKES TJ, DANSBY LM, et al: Towards an understanding of oedema. BMJ 318:1610-1613, 1999
33. KARA T, SOMERS VK: Therapeutic strategies for orthostatic intolerance: Mechanisms, observations, and making patients feel better. Am J Med 112:419-421, 2002
34. DAN D, HOAG JB, ELLENBOGEN KA, et al: Cerebral blood flow velocity declines before arterial pressure in patients with orthostatic vasovagal presyncope. J Am Coll Cardiol 39:1039-1045, 2002
35. TAKENAKA K, SUZUKI Y, UNO K, et al: Effects of rapid saline infusion on orthostatic intolerance and autonomic tone after 20 days bed rest. Am J Cardiol 89:557-561, 2002
36. YALCIN AU, SAHIN G, EROL M, BAL C: Sertraline hydrochloride treatment for patients with hemodialysis hypotension. Blood Purif 20:150-153, 2002
37. KIMMERLY DS, SHOEMAKER JK: Hypovolemia and neurovascular control during orthostatic stress. Am J Physiol (Heart Circ Physiol) 282:H645-H655, 2002
38. WIKSTRAND J, BERGLUND G, TUOMILEHTO J: Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence. Circulation 84:VI93-100, 1991
39. GRUNDY SM, BALADY GJ, CRIQUI MH, et al: Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation 95:2329-2331, 1997
40. GRUNDY SM, BALADY GJ, CRIQUI MH, et al: Primary prevention of coronary heart disease: guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation 97:1876-1887, 1998
41. GRUNDY SM: Primary prevention of coronary heart disease: Integrating risk assessment with intervention. Circulation 100:988-998, 1999
42. LA ROSA JC: Prevention and treatment of coronary heart disease: Who benefits? Circulation 104:1688-1692, 2001
43. ADES PA: Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 345:892-902, 2001
44. BRAUNWALD E: Expanding indications for beta-blockers in heart failure. N Engl J Med 344:1711-1712, 2001
45. PACKER M, COATS AJ, FOWLER MB, et al: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658, 2001
46. VASAN RS, BENJAMIN EJ: Diastolic heart failure-no time to relax. N Engl J Med 344:56-59, 2001
47. WOODROW G, OLDROYD B, STABLES G, et al: Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis. Nephrol Dial Transplant 15:862-866, 2000
48. POSTHUMA N, TER WEE PM, VERBRUGH HA, et al: Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltra-tion and 24-h dialysate creatinine clearance. Nephrol Dial Transplant 12:550-553, 1997
49. POSTHUMA N, TER WEE PM, DONKER AJM, et al: Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. Perit Dial Int 20(Suppl 2):S106-S113, 2000
50. DAVIES SJ, PHILLIPS L, NAISH PF, RUSSELL GI: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051, 2001
51. PANIAGUA R, AMATO D, VONESH E, et al: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
52. BURKART J: A novel "bimodal" use of icodextrin peritoneal dialysis solutions. Kidney Int 53:1089-1090, 1998
53. GOKAL R: Newer peritoneal dialysis solutions. Adv Ren Replace Ther 7:302-309, 2000
54. KREDIET RT, HO-DAC-PANNEKEET MM, IMHOLZ AL, STRUIJK DG: Icodextrin's effects on peritoneal transport. Perit Dial Int 17:35-41, 1997
55. MISTRY CD, GOKAL R, PEERS E: A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 46:496-503, 1994
56. PLUM J, GENTILE S, VERGER C, et al: Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 39:862-871, 2002
57. VONESH EF, STORY KO, O'NEILL WT: A multinational clinical validation study of PD ADEQUEST 2.0. PD ADEQUEST International Study Group. Perit Dial Int 19:556-571, 1999
58. VONESH EF: Membrane transport models and computerized kinetic modeling applied to Automated Peritoneal Dialysis, in Automated Peritoneal Dialysis, edited by RONCO C, AMICI G, FERIANI M, VIRGA G, New York, Karger, 1999
59. VONESH EF, KESHAVIAH PR: Applications in kinetic modeling using PD ADEQUEST. Perit Dial Int 17(Suppl 2):S119-S125, 1997
60. VONESH EF, BURKHART J, MCMURRAY SD, WILLIAMS PF: Peritoneal dialysis kinetic modeling: Validation in a multicenter clinical study. Perit Dial Int 16:471-481, 1996
61. WANG T, HEIMBURGER O, CHENG H, et al: Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int 52:1068-1076, 1997
62. WANG T, HEIMBURGER M, BERGSTRÖM J, LINDHOLM B: Optimizing solute clearance and fluid balance with high-fill volumes: The effect of hypertonic dialysate. Am J Kidney Dis 31:1050-1057, 1998
63. FUKATSU A, KOMATSU Y, SENOH H, et al: Clinical benefits and tolerability of increased fill volumes in Japanese peritoneal dialysis patients. Perit Dial Int 21:455-461, 2001
64. BERNARDINI J, NAGY M, PIRAINO B: Pattern of noncompliance with dialysis exchanges in peritoneal dialysis patients. Am J Kidney Dis 35:1104-1110, 2000
65. PIRAINO B, BERNARDINI J: The problem of compliance with PD exchanges. Semin Dial 13:160-162, 2000